P-36 - Medical Assisted Treatment of Opiate Dependence With Buprenorphine/naloxon (suboxone) of Heroin Addicts in Prison who are Aging Penalties

[1]  L. Kapur-Pojskič,et al.  Association of dopamine receptor gene polymorphism and psychological personality traits in liability for opioid addiction. , 2013, Bosnian journal of basic medical sciences.

[2]  N. Mehić-Basara,et al.  Treatment of addicts in Bosnia and Herzegovina--constraints and opportunities. , 2012, Psychiatria Danubina.

[3]  I. Maremmani,et al.  Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment. , 2010, The American journal on addictions.

[4]  C. Rück,et al.  A Stepped Care Strategy Using Buprenorphine and Methadone Versus Conventional Methadone Maintenance in Heroin Dependence: A Randomized Controlled Trial , 2007 .

[5]  M. Heilig,et al.  1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial , 2003, The Lancet.

[6]  M. Hasanovic,et al.  P-33 - Gender Aspects of Epidemiological Characteristics of Heroin Addicts Clinicaly Treated in Psychiatry Department From North-eastern Post-war Bosnia and Herzegovina , 2012, European Psychiatry.

[7]  M. Hasanovic,et al.  P-34 - Quality of Life of Heroin Addicts and Their Family Members Improved During Medical Assisted Treatment of Opiate Dependence With Buprenorphine/naloxon (suboxone) , 2012, European Psychiatry.

[8]  M. Hasanovic,et al.  P-35 - Some Edemiological Characteristics of Opiate Addicts With Hepatitis c who are in Substitution Maintainance Therapy With Buprenorphine/naloxone (suboxone) in Bosnia-herzegovina , 2012, European psychiatry.